Transpire Bio Announces Progress in Clinical Development with Initiation of a New Human Subject Study for Asthma and COPD Inhaled Drug Program
News WESTON, Fla., Jan. 13, 2024 (GLOBE NEWSWIRE) Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the commencement of a new human subject study for its inhalation therapy program targeting asthma and chronic obstructive pulmonary disease (COPD). This advancement builds on the promising results from a previous clinical […]
Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
News Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine WESTON, Fla., July 7, 2025 (GLOBE NEWSWIRE) — Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has announced a definitive agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the treatment […]
Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program
News Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program WESTON, Fla., Dec 17, 2024 (GLOBE NEWSWIRE) Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced a definitive agreement with […]
Transpire Bio Announces Corporate Office Expansion
News WESTON, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an agreement to expand the footprint of its global headquarters in South Florida. The expansion is expected to accommodate additional executive leadership and administrative […]
Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment
News Transpire Bio Strengthens Its Leadership Team with a New Senior-Level Appointment WESTON, Fla., July 7, 2025 (GLOBE NEWSWIRE) — Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced the addition of another senior-level inhalation expert to their leadership team, filling a key position. Dr. […]
Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing
News Transpire Bio Strengthens Leadership Team with New Appointments to Lead Commercialization, Quality Assurance, and Manufacturing WESTON, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced the addition of three distinguished biopharma industry executives to its leadership team. Joining […]
Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program
News WESTON, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled medicines, today announced that the company has completed the first human subject study of its inhalation product for the treatment of asthma and chronic obstructive pulmonary disease (COPD). According to statistics from the World Health Organization, […]
Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility
News Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility WESTON, Fla., October 30, 2023 (PR NEWSWIRE) — Transpire Bio, a development-stage biopharmaceutical company, was joined by local and state elected officials and industry leaders to celebrate the opening of its new research facility and global headquarters in Weston. […]
Transpire Bio announces agreement with INTO for the development of three inhaled medicines
News Transpire Bio announces agreement with INTO for the development of three inhaled medicines WESTON, Fla., July 7, 2025 (GLOBE NEWSWIRE) Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has today announced a definitive agreement with INTO (Inhalation Together) to develop TRB-5, TRB-6 and TRB-7, inhaled medicines […]
